Position-Specific Effects of Base Mismatch on Mammalian Topoisomerase II DNA Cleaving Activity
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 35 (1) , 153-159
- https://doi.org/10.1021/bi951736p
Abstract
To further define the nucleic acid determinants of DNA site recognition by mammalian topoisomerase II, base mismatch effects on the enzyme DNA cleavage activity were determined in a 36-bp synthetic oligonucleotide corresponding to SV40 DNA. DNA cleavage sites induced by topoisomerase II without or with the antitumor drugs teniposide, idarubicin, or amsacrine were mapped using sequencing gels. Selected mismatches were studied, and always one of the two strands had the wild-type sequence. The effects of base mismatches were independent from the studied drugs. Mismatches introduced at the −4, −3, −2, or −1 positions, relative to the enzyme cleavage site, often abolished, or much reduced, DNA cleavage, whereas those at +1 and +2 positions often increased DNA breakage or were without influence. Mismatches at more distant positions, e.g., −7, −8, etc., had no effect. Those at positions −5 and −6 sometimes increased cleavage levels. These effects were always observed at sites already cleaved in the wild-type oligomer; new sites of cleavage were not induced by the studied mismatches. These results were obtained both for the native murine topoisomerase II and for the two recombinant human isozymes. No difference between topoisomerases II α(p170) and β(p180) was seen in their response to mismatches. The results demonstrate that topoisomerase II recognition of the DNA site of cleavage requires fully paired nucleotides at the 3‘ terminus. Nevertheless, similarly to other DNA strand transferase enzymes, both topoisomerase II isoforms may have a sequence-specific nicking activity at the 5‘ side of unpaired bases.Keywords
This publication has 23 references indexed in Scilit:
- Conformational Drug Determinants of the Sequence Specificity of Drug-stimulated Topoisomerase II DNA CleavageJournal of Molecular Biology, 1994
- Small Deletion and Insertion Mutations Induced by the Topoisomerase II Inhibitor Teniposide in CHO Cells and Comparison with Sites of Drug-stimulated DNA Cleavage in VitroJournal of Molecular Biology, 1993
- DNA topoisomerase-trapping antitumour drugsEuropean Journal Of Cancer, 1992
- Catalytic function of DNA topoisomerase IIBioEssays, 1991
- Chromosome assembly in vitro: Topoisomerase II is required for condensationCell, 1991
- DNA topoisomerases and models of sister-chromatid exchangeMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1989
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Biochemical basis for the interactions of type I and type II topoisomerases with DNAPharmacology & Therapeutics, 1989
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- DNA topoisomerase II is required at the time of mitosis in yeastCell, 1985